Welsh KJ, Barlow M, Tenover FC, Biddle JW, Rasheed K, Clark LA, McGowan JE. Experimental prediction of the evolution of ceftazidime resistance in the CTX-M-2 extended-spectrum beta-lactamase. Antimicrobial agents and chemotherapy. 2005;49(3):1242–1244.

Hall BG, Salipante SJ, Barlow M. Independent Origins of Subgroup Bl+ B2 and Subgroup B3Metallo-β-Lactamases. Journal of molecular evolution. 2004;59(1):133–141.

Hall BG, Barlow M. Evolution of the serine β-lactamases: past, present and future. Drug Resistance Updates. 2004;7(2):111–123.

Salipante SJ, Barlow M, Hall BG. GeneHunter, a transposon tool for identification and isolation of cryptic antibiotic resistance genes. Antimicrobial agents and chemotherapy. 2003;47(12):3840–3845.

Hall BG, Barlow M. Structure-based phylogenies of the serine β-lactamases. Journal of molecular evolution. 2003;57(3):255–260.

Hall BG, Salipante SJ, Barlow M. The metallo-β-lactamases fall into two distinct phylogenetic groups. Journal of molecular evolution. 2003;57(3):249–254.

Barlow M, Hall BG. Experimental prediction of the evolution of cefepime resistance from the CMY-2 AmpC β-lactamase. Genetics. 2003;164(1):23–29.

Barlow M, Hall BG. Experimental prediction of the natural evolution of antibiotic resistance. Genetics. 2003;163(4):1237–1241.

Barlow M, Hall BG. Phylogenetic analysis shows that the OXA b-lactamase genes have been on plasmids for millions of years. Journal of molecular evolution. 2002;55(3):314–321.

Barlow M, Hall BG. Origin and evolution of the AmpC β-lactamases of Citrobacter freundii. Antimicrobial agents and chemotherapy. 2002;46(5):1190–1198.